Diligence memo · auto-generated · as of July 2, 2026
C2 Therapeutics Inc
C2 Therapeutics Inc has raised $26M over 5 rounds; too few niche peers to rank its valuation yet.
Businessfiled
C2 Therapeutics Inc operates in Pharma, based in Redwood City.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
C2 Therapeutics Inc has raised $26M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $12M on 2014-09-29.
Most recent recorded round closed around 2015-06-05.
Valuation (modeled)modeled
Provath models C2 Therapeutics Inc at approximately $195M (range $7.2M–$1.1B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 12 months.
Last raise 11.1 yr ago; this sector typically re-raises about every 16 months.
Silent for over 3× the sector's normal cadence.
The last round was 2.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 79% of Pharma peers (310 compared).
Modeled value ranks above 76% of those peers.
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.